Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ëàáîðàòîðíàÿ äèàãíîñòèêà > Ôîðóì äëÿ îáùåíèÿ âðà÷åé è ñïåöèàëèñòîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 19.11.2012, 18:15
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,865
Ïîáëàãîäàðèëè 33,445 ðàç(à) çà 31,788 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êàê ïîíèìàþ, èñêóññòâåííûé/àðòåôàêòíûé àíèçîöèòîç - ÿâëåíèå íå òàêîå ÷àñòîå, ÷òîáû èíòåðôåðèðîâàòü çíà÷èòåëüíî ñ èñòèííûì; çà ðóáåæîì ïðåæäå, ÷åì âûäàâàòü ðåçóëüòàòû àíàëèçà, íåðåäêî/âñåãäà?/ ïðîâåðÿþò ãèñòîãðàììû, äàáû èñêëþ÷àòü àðòåôàêòû îò íèõ çàâèñÿùèå (íàïð. õîëîäîâûå àããëþòèíèíû, òðîìáîöèòàðíûå àãðåãàòû); ïîäðîáíåå î àíèçîöèòîçå è îöåíêå ãèñòîãðàìì â íåäàâíåé ïóáëèêàöèè:

The Red Cell Histogram and The Dimorphic Red Cell Population (2011) LabMedicine, 42, 300-308.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
Assandra îäîáðèë(à): cïàñèáî!
OlgaVK îäîáðèë(à): ñïàñèáî, î÷åíü èíòåðåñíî!
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 24.05.2013, 18:05
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,865
Ïîáëàãîäàðèëè 33,445 ðàç(à) çà 31,788 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íåäàâíÿÿ ïóáëèêàöèÿ èç Áðèòàíèè: RDW >= 14% ó äåòåé 13 ìåñ. âîçðàñòà àññîöèèðóåòñÿ ñ ëàòåíòíûì æåëåçîäåôèöèòîì

AIMS: To assess the sensitivity of an adult-derived red cell distribution width (RDW) reference limit in the detection of iron deficiency in young children.

METHODS: Haematological analysis performed on a cohort of 13-month-old healthy term infants of North European ancestry.

RESULTS: 21/98 infants were iron-deficient (>2.5% hypochromic red cells). Of the remaining 77, 35 with RDW >13.9% also had evidence of incipient iron deficiency on the basis of significantly lower haemoglobin (11.5 vs 11.8 g/dl, p=0.046), mean cell volume (75.6 vs 77.8 fl, p=0.002) and mean cell haemoglobin (25.4 vs 26.2 pg, p=0.002) values and higher zinc protoporphyrin (55 vs 44 μmol/molhaem, p<0.001) values than those of the 42 with RDW ≤13.9%.

CONCLUSIONS: An adult-derived RDW reference limit has utility in screening for iron deficiency at the age of 13 months. The incidence of non-anaemic iron deficiency in this group was 52.8%.

Arch Dis Child. 2013 May 22.
Utility of red cell distribution width in screening for iron deficiency.
Hinchliffe RF, Bellamy GJ, Finn A, Bell F, Vora AJ, Lennard L.
Department of Paediatric Haematology, Sheffield Children's NHS Foundation Trust, , Sheffield, UK.

Êîììåíòàðèè ê ñîîáùåíèþ:
Assandra îäîáðèë(à):
OlgaVK îäîáðèë(à): ñïàñèáî!
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 08.12.2014, 18:58
Àâàòàð äëÿ Pavliuk
Pavliuk Pavliuk âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 19.09.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2
Pavliuk *
Question

À âîò è ìåòà-àíàëèç âûøåë:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Our study provides the first systematic review and meta-analysis of prospective studies of RDW and total mortality, fatal and non-fatal CVD events in populations with established CAD. The meta-analysis indicates a significant increased risk for RDW excess and all-cause mortality and CVD events that range from 80% to 120%.

Ñòîèò ëè ê ýòîìó îòíîñèòüñÿ ñåðüåçíî?

Íè îäíîé ïðè÷èíû íå óêàçàíî, ïî÷åìó ýòà âçàèìîñâÿçü èìååò ìåñòî.
Ìî¸ îáúÿñíåíèå:
Òê óâåëè÷åíèå RDW ÷àùå âñåãî ñâèäåòåëüñòâóåò îá àíåìèè, à àíåìèÿ ñîïðîâîæäàåòñÿ òêàíåâîé ãèïîêñèåé, óõóäøàþòñÿ ïðîöåññû Â-îêèñëåíèÿ â ìèîêàðäå. 70% ïèòàíèÿ ìèîêàðäà - Â-îêèñëåíèå æèðîâ, íà îêèñëåíèå æèðîâ íàäî ìíîãî Î2, áîëüøå, ÷åì íà îêèñëåíèå óãëåâîäîâ. À ïðè àòåðîñêëåðîçå èòàê ñíèæàåòñÿ ïîñòóïëåíèå êèñëîðîäà. Ïðè ñòåíîêàðäèè (ðåïåðôóçèè) óñèëèâàþòñÿ ïðîöåññû B-îêèñëåíèÿ, óñóãóáëÿÿ ãèïîêñèþ.

Òî åñòü ìû èìååì ãèïîêñèþ è îò àíåìèè è îò ÈÁÑ. B-îêèñëåíèå íå ìîæåò ïðîõîäèòü ïîëíîöåííî, óñèëèâàåòñÿ äåôèöèò ÀÒÔ. Ïîëó÷àåòñÿ óâåëè÷åíèå RDW ìîæåò ïðèâîäèòü â óâåëè÷åíèþ ôàòàëüíûõ ñîáûòèé.

Åñëè ýòî îäíî èç îáúÿñíåíèé, òî ïî÷åìó ýòî íå íàïèñàëè â ìåòà-àíàëèçå?
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 08.12.2014, 19:10
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,865
Ïîáëàãîäàðèëè 33,445 ðàç(à) çà 31,788 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Pavliuk Ïîñìîòðåòü ñîîáùåíèå
Íè îäíîé ïðè÷èíû íå óêàçàíî, ïî÷åìó ýòà âçàèìîñâÿçü èìååò ìåñòî.
Ìî¸ îáúÿñíåíèå:
...
Åñëè ýòî îäíî èç îáúÿñíåíèé, òî ïî÷åìó ýòî íå íàïèñàëè â ìåòà-àíàëèçå?
Òàê Âàñ æå íåò ñðåäè àâòîðîâ ìåòà-àíàëèçà, âîò è íåò èìåííî Âàøåé ãèïîòåçû - íàïèøèòå ïèñüìî ê èçäàòåëþ/ðåäàêöèè æóðíàëà ñ îáîñíîâàíèåì Âàøåé ãèïîòåçû, ïîäòâåðæäàÿ âñå Âàøè âûâîäû ñîîòâåòñòâóþùèìè ññûëêàìè, è ïîñìîòðèòå ÷òî Âàì îòâåòÿò...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 10.12.2014, 08:51
Àâàòàð äëÿ Pavliuk
Pavliuk Pavliuk âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 19.09.2013
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2
Pavliuk *
Íó ìåíÿ áîëüøå èíòåðåñóåò, ñòîèò ëè îòíîñèòüñÿ ñåðüåçíî ê òàêîìó ìåòà àíàëèçó? )

Òàì âîîáùå íåò ãèïîòåç. ß õîòü êàêóþ-òî àáðàêàäàáðó ïðèäóìàëà))))
Âñå ðàâíî, òåïåðü, ñìîòðÿ íà àíàëèç êðîâè ÷åëîâåêà ñ ÈÁÑ, ÿ áóäó îáðàùàòü âíèìàíèå íà RDW)

Âñå ó Âàñ õîòåëà ñïðîñèòü. ß ôåððèòèí ïðîâåðÿþ ó ìíîãèõ ïàöèåíòîâ, ïðè óðîâíå ìåíåå 50 íàçíà÷àþ ëå÷åíèå. (Åñëè åñòü âîçìîæíîñòü è òðàíñôåððèí, ÎÆÑÑ). È âîò êàê-òî â ëàáîðàòîðèè íà ìåíÿ íà îðàëè ñ ïîñûëîì, ÷òî íå íàäî ïîæèëûì ëþäÿì, ëþäÿì ñ îíêîëîãèè è ÈÁÑ, íàçíà÷àòü áîëáëèê äîçèðîâêè æåëåçà. Îáúÿñíåíèå - èòàê ïîâûøåíî ÏÎË, ìíîãî àêòèâíûõ ôîðì êèñëîðîäà èòä.
Íà ñàìîì äåëå åñòü òàêàÿ ëîãèêà?
ß èñêàëà, íè÷åãî íå íàøëà.

Íàïðèìåð:
Ïàöèåíò 1. Æåíùèíà 35 ëåò. Ôåððèòèí - 6 ìêã/ë. Ãåìîãëîáèí - 110 ã/ë.
Ïàöèåíò 2. Æåíùèíà 65 ëåò, ñ ÈÁÑ, â àíàìíåçå îíêîëîãè÷åñêîå çàáîëåâàíèå. Ôåððèòèí 6 ìêã/ë. Ãåìîãëîáèí - 110 ã/ë.
Ñòîèò ëè ïðè íàçíà÷åíèè ëå÷åíèÿ ïîäõîäèòü äèôôåðåíöèðîâàííî? Îäíîé íàçíà÷èòü 2 òàáëåòêè Ñîðáèôåðà (640 ìã), âòîðîé 1 (320)?
Èëè ýòî âñå áðåä?
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 11.12.2014, 23:06
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,865
Ïîáëàãîäàðèëè 33,445 ðàç(à) çà 31,788 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öåëü ìåòà-àíàëèçà - ñóììèðîâàòü èìåþùèéñÿ ýâèäåíñ, ïî÷åìó ýòî ïðîèñõîäèò (ïðè÷èíû, ãèïîòåçû) èçëàãàþòñÿ â ñòàòüÿõ èëè îáçîðàõ, êîèõ ïðåâåëèêîå ìíîæåñòâî ïî òåìå (â òîì ÷èñëå è â ñâîáîäíîì äîñòóïå).

Âû âðà÷ êàêîé ñïåöèàëüíîñòè, ÷òî ïîçâîëÿåòå â ëàáîðàòîðèè îðàòü íà ñåáÿ ñ ïîñûëîì?

÷òî ýòî çà ñëîâî "áîëáëèê"?

Ïðî àíåìèè ó ïîæèëûõ (â òîì ÷èñëå ÆÄÀ) çäåñü [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

ïðè æåëàíèè ìîæíî íàéòè ñîîòâ. ìàòåðèàëû ïðè íàëè÷èè ÈÁÑ èëè îïóõîëè

Êàêèõ òîëüêî îáüÿñíåíèé íå ïðèäóìàþò "ñïåöèàëèñòû", ÷òîáû íå ðàáîòàòü íà ðàáî÷åì ìåñòå: "ÏÎË, ìíîãî àêòèâíûõ ôîðì êèñëîðîäà"; åñëè áû èõ ç/ï çàâèñåëà îò êà÷åñòâà è êîëè÷åñòâà ïðàâèëüíî ñäåëàííûõ àíàëèçîâ, òî ãëóïîñòåé áû íå ãîâîðèëè
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 12.12.2014, 16:11
Àâàòàð äëÿ Assandra
Assandra Assandra âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.08.2009
Ãîðîä: Êèåâ
Ñîîáùåíèé: 2,044
Ñêàçàë(à) ñïàñèáî: 17
Ïîáëàãîäàðèëè 665 ðàç(à) çà 643 ñîîáùåíèé
Assandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìåíÿ â âûøåïðèâåäåííîì îáçîðå (â ïîñòå 18) ñìóùàåò ñëåäóþùåå:

"Inclusion and exclusion criteria

Inclusion criteria were the following: (I) serum or plasma RDW was the determinant...

Data synthesis and statistical methods

We extracted the results of the highest versus lowest RDW concentrations"

È ïîäîáíîå ïî îäíîé èç ññûëîê (10)

«We aimed to investigate the association of serum red cell distribution width (RDW) levels and fQRS in patients with non-ST elevated acute coronary syndrome»

Ó ìåíÿ ïðîáëåìû ñ ïåðåâîäîì???
×òî ýòî çà ñûâîðîòî÷íûé RDW è êàêàÿ ó íåãî ìîæåò áûòü êîíöåíòðàöèÿ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 12.12.2014, 16:21
Àâàòàð äëÿ Assandra
Assandra Assandra âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.08.2009
Ãîðîä: Êèåâ
Ñîîáùåíèé: 2,044
Ñêàçàë(à) ñïàñèáî: 17
Ïîáëàãîäàðèëè 665 ðàç(à) çà 643 ñîîáùåíèé
Assandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Àâòîðû - êèòàéöû. Ìîæåò, ýòî ó íèõ ïðîáëåìû ñ àíãëèéñêèì?
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 12.12.2014, 21:01
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,865
Ïîáëàãîäàðèëè 33,445 ðàç(à) çà 31,788 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Assandra Ïîñìîòðåòü ñîîáùåíèå
×òî ýòî çà ñûâîðîòî÷íûé RDW è êàêàÿ ó íåãî ìîæåò áûòü êîíöåíòðàöèÿ?
Äà ïîõîæå ýòîò àíàëèç äåëàëè íå ñîâñåì ñïåöèàëèñòû â ëàá. ìåäèöèíå, à ýòîò òîâàðèñ÷-ðåäàêòîð èç æóðíàëà ïðîïóñòèë (èëè áûë â îòïóñêå, à òàêèå æå äðóãèå íåñïåöû ïðîñòî íå çàìåòèëè) ýòè ñëîâåñíûå ëÿïû:

Section Editor (Systematic Review and Meta-analysis)
Zhi-De Hu, M.M Department of Laboratory Medicine, General Hospital of Jinan Military Command Region.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 03:09.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.